Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pinpointing the Factors Affecting Clinical Study Experiences of Schizophrenia Patients

NCT05870722 is registered in ClinicalTrials.gov with Power Life Sciences Inc. as lead sponsor.

NCT NCT05870722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pinpointing the Factors Affecting Clinical Study Experiences of Schizophrenia Patients
Lead sponsor
Power Life Sciences Inc.
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2024
Completion date
June 30, 2026
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia